lymphoma: be prevented

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents cancer
Weight: 0.65
, type
Weight: 0.63
, breast cancer
Weight: 0.60
, blood
Weight: 0.58
, tumor
Weight: 0.58
Siblings skin cancer
Weight: 0.39
, melanoma
Weight: 0.38
, liver cancer
Weight: 0.38
, lung cancer
Weight: 0.38
, prostate cancer
Weight: 0.38

Related properties

Property Similarity
be prevented 1.00

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.11
Rule weight: 0.13
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.44
¬ Remarkable(lymphoma, be prevented)
Evidence: 0.44
¬ Remarkable(prostate cancer, be prevented)
0.10
Rule weight: 0.13
Evidence weight: 0.72
Similarity weight: 1.00
Evidence: 0.44
¬ Remarkable(lymphoma, be prevented)
Evidence: 0.64
¬ Remarkable(liver cancer, be prevented)
0.09
Rule weight: 0.13
Evidence weight: 0.69
Similarity weight: 1.00
Evidence: 0.44
¬ Remarkable(lymphoma, be prevented)
Evidence: 0.71
¬ Remarkable(lung cancer, be prevented)
0.09
Rule weight: 0.13
Evidence weight: 0.69
Similarity weight: 1.00
Evidence: 0.44
¬ Remarkable(lymphoma, be prevented)
Evidence: 0.71
¬ Remarkable(lung cancer, be prevented)

Remarkability from sibling implausibility

0.57
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.70
Plausible(lymphoma, be prevented)
Evidence: 0.64
Remarkable(liver cancer, be prevented)
Evidence: 0.43
¬ Plausible(liver cancer, be prevented)
0.57
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.70
Plausible(lymphoma, be prevented)
Evidence: 0.71
Remarkable(lung cancer, be prevented)
Evidence: 0.57
¬ Plausible(lung cancer, be prevented)
0.57
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.70
Plausible(lymphoma, be prevented)
Evidence: 0.71
Remarkable(lung cancer, be prevented)
Evidence: 0.57
¬ Plausible(lung cancer, be prevented)
0.56
Rule weight: 0.60
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.70
Plausible(lymphoma, be prevented)
Evidence: 0.44
Remarkable(prostate cancer, be prevented)
Evidence: 0.45
¬ Plausible(prostate cancer, be prevented)

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.70
Plausible(lymphoma, be prevented)
Evidence: 0.71
¬ Salient(lymphoma, be prevented)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.71
Salient(lymphoma, be prevented)
Evidence: 0.81
¬ Typical(lymphoma, be prevented)
Evidence: 0.44
¬ Remarkable(lymphoma, be prevented)

Typical implies Plausible

0.36
Rule weight: 0.48
Evidence weight: 0.76
Similarity weight: 1.00
Evidence: 0.70
Plausible(lymphoma, be prevented)
Evidence: 0.81
¬ Typical(lymphoma, be prevented)

Typicality and Rermarkability incompatibility between siblings

0.11
Rule weight: 0.14
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.44
¬ Remarkable(lymphoma, be prevented)
Evidence: 0.43
¬ Typical(liver cancer, be prevented)
0.10
Rule weight: 0.14
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.44
¬ Remarkable(lymphoma, be prevented)
Evidence: 0.53
¬ Typical(prostate cancer, be prevented)
0.10
Rule weight: 0.14
Evidence weight: 0.75
Similarity weight: 1.00
Evidence: 0.44
¬ Remarkable(lymphoma, be prevented)
Evidence: 0.56
¬ Typical(lung cancer, be prevented)
0.10
Rule weight: 0.14
Evidence weight: 0.75
Similarity weight: 1.00
Evidence: 0.44
¬ Remarkable(lymphoma, be prevented)
Evidence: 0.57
¬ Typical(lung cancer, be prevented)